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INTRODUCTION
In mammals, the generation of new nerve cells, referred to as neurogenesis, is extensive early in development but becomes largely restricted to two discrete areas in adult brain; the subgranular zone of dentate gyrus (DG) [1] and the subventricular zone (SVZ) [2] . The SVZ neurogenic niche is composed of a heterogeneous population of cells [3, 4] with two cell compartments distinguished on the basis of their proliferative potential. The nonproliferative compartment is composed of ependymal cells, which are essential for maintaining the neurogenic niche by providing necessary factors, many of which are yet to be identified. By producing soluble molecules such as noggin, a BMP antagonist, ependymal cells can direct neural stem/progenitor cell (NSPC) fate toward a neurogenic lineage [5] . The proliferative compartment is composed of stem cells and transit amplifying progenitor daughter cells; these cells give rise to neuroblasts which eventually migrate tangentially via the rostral migratory stream (RMS) to reach the olfactory bulb (OB), where they functionally differentiate and integrate existing networks [6] .
Hydrocephalus in humans is associated with defects in cerebral spinal fluid (CSF) circulation 2 and/or production, resulting in enlargement of brain ventricular spaces and massive loss of brain parenchyma [7] . Recent studies have shown a causal link between ciliated ependymal cell dysfunction and hydrocephalus [8] . Ependymal cells constitute the specialized epithelium lining the ventricular spaces and play a necessary role in production, transport and filtration of CSF molecules [9, 10] . Although neurogenic abnormalities and ependymal cell function defects are often associated with hydrocephalus [11, 12] the genetic alterations underlying these defects are poorly understood [7] .
The c-myb gene encodes a proto-oncogene transcription factor, highly expressed in proliferating cells of both the developing hematopoietic system and in human leukemias [13] , maintaining cells in an undifferentiated state by repressing terminal differentiation and driving proliferation [14, 15] . In addition to its role in the hematopoietic system, we have previously shown that c-myb is required for normal colon development [16] and that it is highly expressed in numerous colon cancer cell lines [15, 17] . Our recent data extended these findings to show that c-Myb specifically regulates progenitor cell homeostasis in the colon crypt [18] and skin growth [19] , implying that c-Myb may have a more general role in modulating progenitor cells in many more tissues than previously thought. However, less is known about the role of c-myb in the proliferative compartments of other tissues. Although c-myb mRNA expression has been reported previously in mouse and rat brain [20, 21] , its function in normal brain development and cellular proliferation remains unexplored. Previous work in our laboratory has shown that c-myb mRNA levels in the brain decrease throughout the course of murine embryogenesis [20] , but persist in neurogenic foci in the adult brain, implying that c-Myb may play a role in neurogenic zones where stem/progenitor cells reside.
Mice devoid of c-Myb display a block in definitive hematopoiesis resulting in early embryonic lethality [22, 23] and severe defects in colon architecture [16] . Here we show that cMyb is expressed in NSPCs in the neurogenic regions of the adult mouse brain. To study the role of c-Myb in NSPC function, we employed the Cre/loxP recombination system to specifically disrupt c-Myb expression in NSPCs. Although mice with brain-specific loss of c-myb (c-myb nesCre mutant mice) were viable, the loss of c-Myb specifically in NSPCs and their progeny resulted in a distinct phenotype, including enlarged ventricular spaces and olfactory bulb hypertrophy. One fifth of the mutants exhibited severe hydrocephalus, associated with massive loss of brain parenchyma. At the cellular level, we found ependymal cell layer alteration, with a decrease in both the length and number of cilia and impaired neurogenesis. Analysis of proliferation dynamics both in vivo and in neurosphere cultures shows that loss of c-Myb causes specific cell-cycle defects. Altogether, our data suggest c-myb has an important role in supporting neurogenesis in the adult brain.
MATERIAL AND METHODS

Mice.
To generate the nervous system-specific cmyb mutant mice, we used mice in which c-myb exons 3 to 6 were flanked with loxP (F) sites [23] . Mice harboring the c-myb F allele were crossed with transgenic mice possessing the Cre recombinase gene under the control of the nestin promoter and enhancer [24, 25] . Control mice used were c-myb F/F or littermate NesCre mice. Severely hydrocephalic mutants were excluded from all cell counting and neurogenesis analysis.
Histology. Mice were perfused with cold 4% paraformaldehyde (PFA). Depending on the age of the mice, brains were either dissected (adult) or whole heads (E18.5) were post-fixed overnight in 4% PFA at 4 o C prior to embedding in paraffin wax. Paraffin blocks were sectioned on a microtome at a thickness of 6 m; sections were cleared of paraffin and rehydrated through an ethanol series.
BrdU labeling and detection. For the BrdU pulse experiments, mice were injected intraperitoneally with 100 mg/kg BrdU and sacrificed 2.5 hours later. Following blocking of endogenous peroxidase activity in 3% hydrogen peroxide for 10 min, sections were rinsed in PBS and treated with 2 N HCl in PBS with 0.1% Triton-X100 for 30 min. After rinses, sections were processed for staining with mouse monoclonal anti-BrdU (1:500; Dako) and ImmPress Kit (Vector Laboratories). Staining was visualized with diaminobenzidine (DAB; DakoCytomation) and H 2 O 2 . For the 2 wk BrdU pulse experiments, mice received BrdU in their drinking water ad libitum at 1mg/ml. BrdU antibodies (1:100) were detected using fluorescent antibodies Alexa Fluor 594 goat antimouse IgG (1:400, Molecular Probes).
Immunohistochemistry (IHC)
For c-Myb Mab 1.1 [26] , S-100 (rabbit anti-S-100 1:2000, Dako) and Polaris (rabbit sera antiPolaris 1:500, kindly provided by Dr B. Yoder [27] ) staining, sections were subjected to pressure antigen retrieval in EDTA 1 mM pH 8 buffer. Primary antibodies were detected using the ImmPress Kit (Vector Laboratories) kit and staining was visualized with DAB and H 2 O 2.
Double labeling experiments
For BrdU/GFAP or DCX labeling: following antigen retrieval, adjacent sections were incubated overnight at 4° C in goat antiDoublecortin antibody 1:100 in PBS (DCX (C18), Santa Cruz) or in rabbit anti-GFAP antibody 1:200 in PBS (DakoCytomation). BrdU labeling was performed as previously described. For c-Myb and GFAP, DCX or S-100 double labeling, high pH antigen retrieval solution (DakoCytomation) was employed for c-Myb detection. For Phospho-Histone-H3 (PH3) and PCNA double labeling, coronal sections were stained after citric acid antigen retrieval for PCNA and PH3 cell cycle marker respectively using a mouse anti-PCNA antibody (1/100, BD Biosciences) and a rabbit anti-PH3 antibody (1:250, Upstate Cell Signaling Solutions). Secondary detection was performed using Double labeling of cells for specific marker (PCNA/PH3, DCX/BrdU or GFAP/BrdU), were analyzed through the z-plane in 0.3µm optical sections using a confocal microscope (FV1000 Biorad). When necessary, sections were rotated in the z-plane. Three equivalent planes in each of 3 sections (granular and periglomerular layers of the OB) of each animal (n=3) were scanned at a magnification of x100.
Neurosphere Cultures. NSPCs were derived from adult mutant mice and control littermates and maintained as neurospheres as previously described [28] . The neurosphere cultures were passaged every 7 days for 10 passages and the cumulative number of cells generated over this time was calculated. For differentiation studies, dissociated neurospheres were plated on poly-dlornithine/laminin coated 8-well chamber slides (Falcon) at 1x10 [5] cells/well and differentiated for 3 days in mitogen free medium in the presence of 1% fetal calf serum. Following fixation in 4% PFA, neurons were detected by immunostaining with mouse anti-βIII-tubulin (1:2000, Promega) and sheep anti-mouse-Cy3 (1:1000, Jackson Immunoresearch), while astrocytes were detected using rabbit anti-GFAP (1:500, Dako) and goat anti-rabbit-Cy2 (1:1000, Jackson Immunoresearch). For BrdU proliferation assays, 10 [4]/cm [2] NSPCs were plated onto poly-l-ornithine/laminin coated slides. After 4 days, cultures were BrdU pulsed for 1h prior to 4 % PFA fixation and BrdU detection. For self-renewal assays and neurosphere diameter analysis, neurospheres were dissociated and re-plated at 10 [4] cells/ml to minimize cell aggregation [2, 29] . The number of regenerated neurospheres was counted after 4 days and diameters of at least 15 randomly chosen neurospheres were measured after 8 days.
Neurospheres were used between passage 1 and 5 for proliferation, self-renewal and quantitative real time RT-PCR determination of c-myb, sox-2 and pax-6 mRNA.
RT-PCR analysis. RNA was extracted using Trizol (Invitrogen) according to manufacturer's instructions. Genomic DNA was removed from RNA by addition of RNAse-free DNAse1 (1 U/μl; Promega, Madison, WI). First strand cDNA was synthesized with Superscript III Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions. All real-time RT-PCR reactions were conducted using an ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA). Eight μl cDNA (1:10 dilution) was combined with 10 μl SyBr Green PCR Master Mix (Applied Biosystems) and 200 nmolar sense and antisense oligonucleotides (Geneworks, Adelaide, Aust.) and amplified using temperatures of 50 o C for 2 minutes and 95 o C for 10 minutes. These initial steps were followed by 45 cycles of 95 o C for 15 seconds and 60 o C for 1 minute. Expression of all genes was normalised to gapdh or β 2 -microglobulin housekeeping genes to determine relative levels of mRNA transcripts.
Statistical analysis. For both in vivo and in vitro
experiments, statistical analyses were conducted using the StatView computer package. Significance was determined using the two-tailed student t-test or the Mann-Whitney U-test.
RESULTS
c-Myb is expressed in the SVZ neurogenic niche
To extend our previous analysis of c-myb expression in the developing and adult mouse brain, we performed in situ hybridization. During embryogenesis, we found that c-myb mRNA is highly expressed in the neuroepithelium at E12.5 ( Supplementary Fig.  1A ). In the adult mouse brain, c-myb mRNA and protein (Fig. 1B, C 
Loss of c-Myb in brain results in enlarged ventricles
To further explore c-Myb function in brain, we crossed mice harbouring loxP-modified, "floxed" alleles of c-myb [23] and a nestin promoter/enhancer driven Cre-recombinase (Cre) transgene to generate mice devoid of cMyb in neural stem cells and all cells derived from these ( Supplementary Fig. 1 B) . This specific nestin-Cre transgenic line has been widely used to achieve robust nervous-system specific recombination of many "floxed" genes [24, 25] , and previously reported that the action of nestin-driven Cre expression results in efficient gene deletion of loxP flanked sequences within the creb1 gene by E12.5, and essentially complete deletion in post-mitotic neurons by E16 [25] . We show here that c-myb mRNA is lost in brains harboring floxed c-myb alleles and the nestin-Cre transgene ( Supplementary Fig. 1  C) . Immunohistochemical detection of c-Myb showed that loss of c-Myb protein expression is extensive in the developing brain by E18.5 ( Supplementary Fig. 1 E) and in the adult SVZ ( Supplementary Fig. 1 G) . c-myb nesCre mutant mice developed normally in utero, thus bypassing the embryonic lethality evident in cmyb -/-mice [22] . Although brain structure was relatively normal at birth, the OBs were significantly smaller in c-myb nesCre brains (Fig. 3  D) . By (Fig. 2 A, B) and sequential MRI scanning ( Supplementary Fig.  3 A, B) . Further morphometric analysis of other brain regions such as the striatum and thalamus indicated that there were no significant changes in these regions. However, nineteen percent (9/47) of the mutants exhibited obvious hydrocephalus, with ventricle enlargement associated with cortical thickening and massive loss of striata, characteristic of hydrocephalus (Fig. 2 C) .
To investigate whether hydrocephalus in our model was due to disruption of cerebrospinal fluid (CSF) circulation, we examined coronal sections throughout the brain, paying special attention to the Aqueduct of Sylvius ( Supplementary Fig. 3 C,D) , the canal that connects the third and fourth ventricles, and the choroid plexus, (Supplementary Fig. 3 E,F) which generates CSF. No differences were observed in these structures between control and mutant mice, indicating that mechanical disruption of CSF flow was unlikely to be an underlying cause of the enlarged ventricles.
Ependymal cells are disorganized and display shorter and fewer cilia in c-myb nesCre mutant mice Ependymal cells are a specialized epithelial cell type lining the ventricles of the brain, and are formed late during embryogenesis (E14-E16) from radial glia in the ventricular zone [30] . Ependymal cell differentiation and apical surface cilia formation occurs during the first postnatal week [30] . To identify these cells we employed IHC for the secretatory protein S-100. We found that the ependymal cells in c-myb nesCre mutant mice were highly disorganized, including disruption in nuclear alignment (Fig. 2 D, E) . Apical S-100 labeling was also disrupted in cmyb nesCre mutant mice with a more diffuse pattern suggesting defective secretatory function. To investigate these cells further, we examined the expression of Polaris, a protein component of the intraflagellar transport system necessary for cilia formation, by IHC. Homozygous hypomorphic mutation of the polaris gene results in cilia loss and hydrocephalus [31] . Polaris staining of ependymal cells evidenced shorter and fewer cilia often clumped and aggregated in c-myb nesCre mutant mice ependymal cells (Fig. 2 F, G) . The distribution of the Polaris protein also differed in the brains of c-myb nesCre mutant mice. Control mice showed characteristic deposition of Polaris at the apical surface of ependymal cells, as well as within the cilia proper, whereas c-myb nesCre mutant mice showed distribution throughout the cytoplasm.
To investigate whether the structure of cilia was also disrupted, we performed scanning electron microscopy (SEM) of the ventricular surfaces ( Fig. 2 H-J) . Densely populated long cilia were seen in control samples (Fig. 2H) , while reduced number of cilia were obvious in myb nesCre samples (Fig. 2I) and only a few long cilia were seen in hydrocephalus samples (Fig. 2J) . Motile cilia are composed of a cylindrical arrangement of nine doublet microtubules and a central pair of singlet microtubules forming the axoneme. Transmission EM analysis on ultrathin brain sections through sub-ventricular sections showed that the axoneme of mutant cilia showed no defects in c-myb nesCre mutant mice ependymal cells (Fig. 2 K-M) . Although motile cilia are required for CSF circulation, loss of cilia is also associated with ventricular enlargement in both humans and mice [8] . These data suggest that the ependymal cell defects observed in the cmyb nesCre mutant brains may in part underpin the enlarged ventricular spaces observed in mutants.
Reduced cell birth and proliferation alters early neurogenesis in c-myb
nesCre mutant mice Ependymal cells regulate CSF flow [9, 10] and thus the movement of soluble growth/survival factors and the establishment of chemotactic gradients in the brain [32] . Consequently, disruption of the ependymal cell layer may alter the function of the adjacent SVZ cells in the neurogenic niche. Therefore, we hypothesized that this observed ependymal cell layer defect impact upon with neurogenesis in vivo.
To measure the extent to which new cells were generated and the level of proliferation, we employed a cumulative BrdU labeling protocol. BrdU is a thymidine analogue that is incorporated in the DNA during the S-phase of cell cycle. Control and c-myb nesCre mutant mice received the BrdU in drinking water for 2 weeks. This protocol allows identification of fast proliferating cells and their progeny as well as slowly dividing cells. We found significantly fewer BrdU + cells in the SVZ of c-myb nesCre mutant mice suggesting that c-Myb loss compromises the proliferative capacity of NSPCs. (Fig. 3 A-C) . TUNEL labeling of brain sections showed that c-Myb loss did not result in increased cell death compared with control brains, implying that the reduced cell birth in mutants could not be attributed to cell loss by increased apoptosis ( Supplementary Fig. 3 G, H). Additionally, we analyzed the mRNA levels of a recognized c-Myb target gene, the cell survival factor bcl-2 [33] by qRT-PCR, and found no change in expression (data not shown).
Newly generated neuroblasts from the rodent SVZ migrate predominantly through the rostral migratory stream (RMS) and integrate within the OBs. Since c-myb nesCre mutant mice exhibited significantly smaller (size and weight) OBs (Fig.  3 D, F) , we investigated whether this was due to reduced production of neuroblasts migrating from the SVZ. To measure neuronal birth, we used doublecortin (DCX) as an early marker of neurogenesis to identify migrating neuroblasts en route to the OB [34] . We found the number of DCX + cells was significantly reduced as quantified on coronal sections throughout the RMS, indicating a potential defect in the generation of neuroblasts from the SVZ of cmyb nesCre mutant mice. The relative crosssectional area of the RMS was also used as a surrogate measure of migrating neuroblasts (DCX + cells) and was reduced in c-myb nesCre mutant mice, compared to controls but this difference was not significant, although less at University of Melbourne Library on October 11, 2007 www.StemCells.com
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Regulation of neural stem cell niche by c-Myb 7 DCX + cells were observed (Fig. 3 E, G-H) . As c-Myb regulates the differentiation of hematopoietic progenitor cells [23] we tested whether the differentiation potential was affected in cells that arise from the SVZ neurogenic zone. In the mouse, newly generated cells in the SVZ reach the OB 5-7 days later to integrate within the granular and periglomerular layers [35] . We performed double labeling experiments for BrdU and DCX or GFAP following 2 week BrdU treatment. Analysis of double stained cells revealed no difference in the percentage of cells co-expressing BrdU and either DCX or GFAP in the granular and glomerular layer of the OB, suggesting that loss of c-Myb does not affect cell fate ( Supplementary Fig. 4 E-F) .
Cell cycle progression is delayed in the brains of c-myb
nesCre mutant mice To further investigate the observed reduction in proliferative capacity of cells in the c-myb nesCre mutant SVZ, we hypothesized that NSPCs from c-myb nesCre mice may have perturbations in the cell cycle, consistent with this role attributed to c-Myb in other cell types [36] [37] [38] . To measure cycling cells actively engaged in S-phase, mice were injected with the exogenous S-phase marker, BrdU and sacrificed after a 2.5 hour exposure. c-myb nesCre mutant brains showed significantly fewer BrdU labeled cells in the SVZ, suggesting there were fewer proliferating NSPCs in S-phase (Fig. 4 A-C) . By using double labeling with PCNA and the G2/M marker, phospho-histone-H3 (PH3), we were able to measure the fraction of cycling cells (PCNA + ) in the mitotic phase (PH3 + ) (Fig. 4 D-I) . The data reveals that c-myb nesCre brains exhibited significantly fewer PH3 + /PCNA + cells compared to control (Fig. 4 J) . Taken together, these data lead us to conclude that c-Myb is required to maintain normal progression through the G1/S and G2/M transitions of the cell cycle (Fig 4 K) .
Reduced neural progenitor cell proliferation is independent of cellular niche
Our findings show that neurogenesis is defective in c-myb nesCre mutant brains due to delayed progression of NSPCs through the cell cycle. To determine whether these effects extended beyond the defects in the ependymal layer of c-myb nesCre mutant mice, we employed the neurosphere assay system to measure cell-intrinsic effects of c-Myb loss on NSPC proliferation.
When we compared the relative c-myb mRNA expression in control adult SVZ-derived neurospheres grown in the presence of bFGF and EGF (proliferating NSPCs) or cells withdrawn from bFGF and EGF in the presence of serum (differentiated neurons and glia), we found that c-myb mRNA was five times lower in the differentiated cells ( Supplementary Fig. 4 A) as was the marker of immature neural cells; nestin. This shows that c-Myb is highly expressed in NSPCs but expression declines in differentiated post-mitotic cells.
To gauge the proliferative potential of mutant and control NSPCs, were grown over ten passages reseeding dissociated neurospheres after each passage at the same density. In growth factor conditions that allow the propagation of neurospheres, where 80-90% of cells are stem and progenitor cells [39] , neurospheres derived from c-myb nesCre mutant mice showed significantly reduced growth potential over time, where myb nesCre cells reached only 60% total cells compared to wild-type cells over 10 weeks. Furthermore, the slope of the line corresponding to growth rate was significantly different to control (P<0.0001), according to linear regression analysis (Fig. 5 B) .
To further characterize whether the defect in cmyb nesCre NSPC propagation was due to a cellintrinsic deficiency in self renewal, we examined the potential of c-myb nesCre NSPCs to form neurospheres following dissociation of neurospheres into single cells (self renewal; Fig.  5 C) . We found no difference in the number of neurospheres generated from c-myb nesCre NSPCs, implying that c-Myb deficient NSPCs retained their self-renewal capacity. This indicated that a defect in proliferation was responsible for the decreased cell number in c-myb nesCre derived neurospheres. This correlates with a reduced diameter (size) of c-Myb mutant neurospheres compared to control (Fig. 5D, Supplementary  Fig. 5A ). Similarly when single cells were seeded at clonal dilution (10μl at 1 cells/μl) in terasaki wells we found that mutant cells generated the same number of neurospheres after 6 days but at a slower rate (supplementary Fig.  5 B-G) . To investigate cellular proliferation independent of the SVZ niche, we performed proliferation analyses by exposing dissociated neurospheres (grown as monolayers) to BrdU for 1 hour (Fig. 5 F-K) . As was seen in the in vivo analysis, cultured NSPCs derived from cmyb nesCre mutant mice exhibited significantly fewer BrdU + cells than controls (Fig. 5 E) , indicating that the proliferation defects seen in the SVZ of c-myb nesCre mutant mice are likely to results from both cell-intrinsic and niche dependent mechanisms following c-Myb loss.
To establish whether NSPCs derived from cmyb nesCre mutant mice retained multipotency in vitro, we induced neurosphere differentiation and analyzed cell differentiation into neurons and glia. In accordance with our in vivo data, cMyb-deficient cells retained the potential to generate both neurons and astrocytes ( Supplementary Fig. 4 B) . The percentage of these cells was not different compared with control cultures (Supplementary Fig. 4 C-D) , indicating that loss of c-Myb does not specifically affect neuronal or glial differentiation.
Loss of c-Myb decreases pax-6 and sox-2 mRNA expression in neurospheres
To identify genes involved in c-Myb-mediated regulation of NSPC proliferation, we hypothesized that the expression of pax-6, a cMyb target gene identified during quail development [40] and involved in neural development and proliferation [41] may be affected by c-myb loss in brain. Pax-6 heterozygous mutant mice display phenotypic parallels to c-myb nesCre mutant mice seen in our study [42] . Sequence alignments of the pax-6 promoters of human and mouse revealed the existence of conserved c-Myb DNA-binding consensus sequences (Supplementary Fig. 6 ). Further analysis of the Pax gene family promoters showed that pax-6 promoters (P0 and P1) exhibit higher frequency of potential DNA binding sites for c-Myb compared to other member of the pax family of genes (Supplementary Fig. 7) . Analysis of pax-6 mRNA expression in mutant and control neurospheres by qRT-PCR showed that pax-6 mRNA expression was significantly reduced in c-myb nesCre mutant neurospheres (Fig. 6 B) suggesting that c-Myb may regulate pax-6 expression in NSPCs. We also investigated the expression of the Pax-6 transcription partner, Sox-2 [43] and identified conserved potential DNA binding sites for c-Myb in the sox-2 promoter region in both human and mouse (Supplementary Fig. 8 ). Indeed sox-2 deletion results in defective neurogenesis associated with ependymal cell layer disruption [44] , which is also observed in c-myb nesCre mutant mice. We asked whether c-Myb loss induced a change in the sox-2 expression level in mutant neurospheres and found using qRT-PCR that similar to pax-6 mRNA and show that sox-2 mRNA is down regulated in c-myb nesCre mutant neurospheres (Fig. 6 A) , indicating that c-Myb may directly or indirectly regulate pax-6 and sox-2 expression.
DISCUSSION
Here we show that c-Myb, a hematopoietic transcription factor and proto-oncogene, has an important role in neural progenitor cell proliferation and maintenance of the neurogenic niche, the first study addressing c-Myb function in neural cells. By in situ hybridization and IHC we showed that c-Myb is expressed in neurogenic regions of the adult mouse brain and that c-Myb expression declines when NSPCs differentiate.
Using a brain specific c-myb knockout mouse model (c-myb nesCre mutant mice) we show that cMyb has a role in post-natal brain development and homeostasis. No obvious phenotype could be seen at the histological level when analysing c-Myb mutant embryos. However, the consequences of c-Myb loss after birth were apparent when ependymal cell differentiation occurs and presumably ependymal cell function becomes important. c-Myb loss caused ependymal cell layer alteration and was associated with enlarged lateral ventricles or hydrocephalus and reduced NSPC proliferation, suggesting that the effect on neurogenesis in vivo results from the synergistic effects of both extrinsic (ependymal cell defect) and intrinsic mechanisms. It is notable that NSPCs in adult brain are closely associated with ependymal cells, which together constitute the neurogenic "niche". Alteration of the stem cell niche results in NSPC dysfunction [45, 46] . Ependymal cells play a key role in the local mixing of CSF molecules and mediate much of the CSF flow throughout the brain. Thus CSF is thought to influence neurogenesis, although the specific factors in CSF which do this are presently unknown [32] . Chroroid plexus cells are specialized ependymal cells that have also been shown to influence NSPCs, emphasizing the functional importance of ependymal cells in supporting the neurogenic niche in adult brain [47] [48] . Alterations to molecules associated with ependymal cilia function may alter NSPC activity. For example ASPM (abnormal spindlelike microcephaly associated) [12] has been proposed to regulate cerebral cortical size as well as neurogenesis. Neurogenic transcription factors also appear to be involved in ependymal cell homeostasis. For example, sox-2 deficient mice display reduced neurogenesis and ependymal cell disruption [44] , comparable with the observed defects we report here in c-Mybdeficient mice. We found that sox-2 expression was decreased in c-Myb-deficient neurospheres compared to controls, suggesting that c-Myb regulates sox-2 expression. Inhibition of sox-2 in mouse embryonic brain leads to reduced S-phase entry and cell cycle exit [49] . Similarly, our in vivo and in vitro experiments revealed that fewer c-myb nesCre mutant NSPCs incorporated BrdU and show reduced progress into mitosis. This is consistent with the role of c-Myb in G 1 /S phase transition in mouse T-and B-cells [36, 38] and progression through the G 2 /M phase in Drosophila is dependent upon the single orthologue, D-Myb [37] .
Concomitantly, we found that c-Myb loss reduced pax-6 expression in neurospheres. In vivo, Pax-6 is expressed in the adult SVZ neurogenic zone [50, 51] and is a regulator of NSPC proliferation [41, 52] . We thus hypothesize that together with its interacting partner Sox-2, Pax-6 may be part of the c-Myb signaling pathway which regulates NSPC proliferation (Fig. 6 C) . Moreover, we found that, (i) similar to Sox-2 [44] , c-Myb is expressed in the ependyma, c-Myb loss resulted in abnormal ependymal cell morphogenesis particularly in the ciliation of these cells, an important characteristic of ependymal cell function. We further propose that c-Myb and Sox-2 are required for ependymal cell differentiation and thus for maintenance of the neurogenic niche and CSF circulation. (ii) c-Myb is also expressed in SVZ cells similar to Sox-2 [44, 53] and 55] . c-Myb may regulate both Sox-2 and Pax-6 gene expression to maintain cell cycle progression and neuroblast generation. This is similar to the hematopoietic stem cell niche where c-Myb regulates c-Kit in progenitor cells on the one hand, while also regulating stem cell factor (c-Kit ligand) expression in fetal liver stromal cells [14] .
In rodents, reduced neurogenesis results in smaller OBs, as many of the new born cells in the SVZ migrate via the RMS to the OB [2] . Consistent with this, the OBs of c-myb nesCre mutant mice were smaller than in controls. Similarly to the neurogenic defects seen in our cmyb nesCre mutant model system, spontaneous mutation of pax-6 leads to reduced OB size in heterozygous mice [42] . We speculate that brain specific deletion of pax-6 might mimic the cell proliferation defects seen in our c-myb cell integrity, which are both critical for maintenance of overall normal brain cellularity. As c-Myb has a role in both NSPC proliferation and ependymal cell integrity and since brainspecific c-Myb loss in mice results in hydrocephaly, perturbation of c-Myb function might contribute to the development of enlarged ventricular spaces and perhaps to development of hydrocephalus. To confirm c-myb loss in neurospheres we performed RT-PCR and show that c-Myb is absent in cMyb nesCre neurospheres "M", but not in controls "C". The expression of the transcription factor creb1 and house-keeping gene gapdh were unchanged. (B) Neural progenitor cell (NPC) growth was reduced in c-myb nesCre as measured by cumulative cell number in neurosphere cultures over 10 passages. To test whether the proliferation / slope of the growth curve of mutant and control cultures were significantly different, data were extrapolated using linear regression analysis. The curve slopes were significantly different (P<0.0001) according to this analysis, demonstrating a clear proliferation difference. (C) The number of neurospheres was unchanged in c-myb nesCre mutant neurosphere culture, however cmyb nesCre mutant neurospheres were smaller in diameter compared with controls (average neurosphere diameter ± sem , *P<0.05, n=3 per genotype) (D). (E-K) For BrdU proliferation assays, NPCs were grown as adherent cell colonies in the presence of mitogens over 4 days and were exposed to 1 hr BrdU incubation. Control (F-H) and mutant (I-K) cultures were labeled for BrdU (green) and counterstained with the nuclear marker propidium iodide (red). The percentage of BrdU labeled cells was quantified in a total of 20 colonies per slide (performed in duplicate; E). Results are expressed as mean ± SEM and **P < 0.01, n=3 per genotype. Scale bars are 20µm. + GFAP + non-neurogenic astrocytes; (iii) S-100 + ependymal cells promote neurogenesis [5] and are essential for CSF microcirculation. Thus, c-Myb is expressed in cells constituting the NSPC niche and our data supports the view that in the absence of c-Myb, the neurogenic niche is functionally impaired.
